HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
The Global Ltd. Holding company for real estate development, building management, and community-integrated hotels.	Japan	3271
The Lifestyle Group Developed luxury/well-being ventures & provided multimedia systems for franchise network growth.	Italy	TLSG
Theranexus A biopharma developing drugs for rare neurological diseases by targeting non-neuronal cells.	France	ALTHX
THE WHY HOW DO COMPANY, Inc. A corporate regeneration platform for business turnarounds, M&A, and succession solutions.	Japan	3823
Tiziana Life Sciences Ltd Biotech firm developing immunotherapies for neurodegenerative diseases like MS and Alzheimer's.	United States of America	TLSA
TME Pharma N.V. Developing therapies for aggressive cancers by neutralizing the tumor microenvironment.	Germany	ALTME
TOKAI LEASE CO.,LTD. Manufactures and leases temporary buildings and fixtures for the construction sector.	Japan	9761
ToolGen Incorporated A biotech firm licensing genome editing patents for therapeutics and agriculture.	South Korea	199800
Trade Desk, Inc. A self-service platform for ad agencies & brands to manage data-driven digital ad campaigns.	United States of America	TTD
Trainers´ House Oyj Consulting & coaching firm driving growth via leadership, sales & strategy execution.	Finland	TRH1V